Tizhen Yan

Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment

PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment

[CPT2 gene mutation analysis and prenatal diagnosis in a family with carnitine palmitoyltransferase II deficiency].

KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia